Sign in
HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma
Journal article   Peer reviewed

HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma

Rehab Yassin, Ali Hajeer, Saeed Alshieban, Ghulam Syed, Bader Alahmari, Ayman Alhejazi, Ahmed Alaskar, Mohsen Alzahrani and Moussab Damlaj
Current research in translational medicine, Vol.67(1), pp.31-33
02/2019
PMID: 30448276

Abstract

HLA PD-1 inhibitor Primary mediastinal B-cell lymphoma

Metrics

1 Record Views

Details